Business Standard

Pfizer in the final stages to ink Covid-19 vaccine deal with Centre

Sources close to the developments had indicated earlier that the price for India could be below $10 per dose, or the lowest in the world

Pfizer CEO Albert Bourla
Premium

Pfizer CEO Albert Bourla said his company will be able to make 3 billion doses of its vaccine by the end of 2021, and around 4 billion vaccines in 2022

Sohini Das Mumbai
US pharma giant Pfizer’s Chief Executive Officer (CEO) Albert Bourla said that the company is in the final stages of signing an agreement with the Indian government to supply its Covid-19 jabs.

According to news agencies, Bourla said, “We are discussing with the Indian government. We are in the final stages of finalising the agreement.” Bourla was speaking at the BioPharma & Healthcare Summit, USA-India Chamber of Commerce (USAIC). “I hope, very soon, we will finalise an agreement with the government,” he added.

Sources close to the developments had indicated earlier that the price for India could be below $10 per dose,

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 22 2021 | 11:44 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com